Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> CANTOR FITZGERALD Latest News

APR 23, 2013 - Benzinga

A Must Read - Share

Celsion Shares Rally as Co. Hires Cantor Fitzgerald to Evaluate Purchase Alternatives, Study Shows Thermodox Improves PFS with Optimized Heating

Celsion Corporation (NASDAQ: CLSN) today is providing a business update, including the latest findings from its analysis of clinical trial results for ThermoDox®, Celsion's proprietary heat-activated liposomal encapsulation of doxorubicin.  Celsion is evaluating ThermoDox® in a Phase III clinical trial for primary liver cancer (the HEAT Study),

Tags: Celsion Shares Rally as Co. Hires Cantor Fitzgerald to Evaluate Purchase Alternatives, Study Shows Thermodox Improves PFS with Optimized Heating,  Cantor Fitzgerald Latest News